11 Results For "glaxo"
 
Bus ad outside of Pfizer
Pneumonia

MSF launches global action against Pfizer and GlaxoSmithKline to cut the price of the pneumonia vaccine

MSF launched a global petition on 12 November 2015, World Pneumonia Day, calling on pharmaceutical companies Pfizer and GlaxoSmithKline (GSK) to reduce the price of the pneumonia vaccine to US$5 per child (for all three doses) in all developing countries and for humanitarian organisations. Press Release - 12 Nov 2015
 
msf-placeholder
India

Patent application for AIDS drug opposed for first time in India

Patents in India endanger global access to affordable medicines and treatment scale-up. Press Release - 30 Mar 2006
 
msf-placeholder
DNDi

Raiding the medicine cabinet

Reinventing the economics of the drug industry presents a different challenge for MSF. Can MSF and its partners really succeed where the pharmaceutical giants, and their multi-billion-dollar budgets, have failed? Yes, claims Bernard Pecoul, who heads MSF's Access to Essential Medicines campaign. "It's an alternative model based on user needs and equitable access rather than profit," he says. Project Update - 3 Jul 2003
 
msf-placeholder
HIV/AIDS

Glaxo cuts price of Aids drugs in poor countries

GlaxoSmithKline, the British pharmaceutical company, has slashed the price of its Aids drugs to sub-Saharan Africa and the rest of the world's poorest countries, it announces today. Project Update - 28 Apr 2003
 
msf-placeholder
HIV/AIDS

Profiteers resell Africa's cheap Aids drugs

The Aids drugs were to be sold at significantly discounted prices to clinics in Senegal, Ivory Coast, the Republic of Congo, Togo and Guinea-Bissau under a scheme to offer some drugs at lower prices to poor countries agreed by Glaxo and four other drug companies with the World Health Organisation. But the shipment was diverted back to Europe by profiteering wholesalers as it arrived at the African airports or even earlier. The latest WHO figures show that only 27,000 have got access to the vital medicines through the two-year-old UN deal called Accelerated Access. Project Update - 4 Oct 2002
 
msf-placeholder
HIV/AIDS

Widening HIV drug access: $100 triple therapy now within reach

Prices should fall within the next few months if the volumes of antiretrovirals ordered are increased. Project Update - 9 Aug 2002
 
msf-placeholder
Kenya

NGOs act to treat patients and call on big pharmaceutical companies to lower prices as promised.

At a press conference today in Nairobi, the Kenya Coalition of NGOs* denounced the lack of transparency in price negotiations between the big pharmaceutical companies, UNAIDS and the Kenyan government and called for the lowering of prices as promised. Press Release - 21 Feb 2001
 
msf-placeholder
HIV/AIDS

Offer to Africa On AIDS Drug

Press Release - 7 Feb 2001
 
msf-placeholder
HIV/AIDS

MSF says pharmaceutical industry must keep its promise

On May 11 this year, the Wall Street Journal reported on an offer that was made by five large pharmaceutical companies (Boehringer lngelheim, Bristol Meyers, Glaxo Wellcome, Merck & Co. and Hoffmann-La Roche) to lower the prices of HIV/AIDS drugs in developing countries. Since then however, little has come of this promise. Project Update - 5 Dec 2000
 
msf-placeholder
HIV/AIDS

The crippled continent

The plight of Miriam Mbwana is a stark example of the tragedy being played out in millions of families across sub-Saharan Africa. Six of her 11 children have died of Aids. Project Update - 2 Dec 2000
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more